Dr Conor Hayden, from the ADAPT Research Ireland Centre and Trinity’s School of Engineering, seeks to commercialise the “Ribbon device”, a non-invasive respiratory sensor that may reduce the impact of undetected respiratory compromise on healthcare costs and patient outcomes.
Enterprise Ireland’s Commercialisation Fund provides funding for two years and allows third-level researchers to translate their research into innovative and commercially viable products. The funding will allow the team to complete key technical and commercial outcomes.
Failure to detect and treat respiratory compromise – associated with increased hospital length-of-stay, costs and mortality risk – results in significant human and economic impact. Currently, there is no continuous, non-invasive monitoring solution for both respiratory rate and volume, which are essential measures for accurate monitoring and early detection.
Click here for more information ...
Students - please use your own personal email address here as school emails block external messages.
